REVELATION BIOSCIENCES, INC. Debt Instrument, Interest Rate During Period
REVELATION BIOSCIENCES, INC. (REVB) reported Debt Instrument, Interest Rate During Period of 2.00% for the 0-month period ending 2021-10-13, per its 10-K filed 2022-04-15.
Discontinued › Notes › Debt Instruments
us-gaap:DebtInstrumentInterestRateDuringPeriod · last filed 2022-04-15
- 2021-10-13: Debt Instrument, Interest Rate During Period 0 month 2.00%.
| Period end | Debt Instrument, Interest Rate During Period 0 month |
|---|---|
| 2021-10-13 | 2.00% 10-K · filed 2022-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |